Thomas C Shea
Overview
Explore the profile of Thomas C Shea including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
89
Citations
2914
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Morris P, Shea T
N C Med J
. 2024 Oct;
85(1):30-32.
PMID: 39374362
Thomas C. Shea, MD, is a retired hematologist-oncologist, researcher, and teacher at the University of North Carolina School of Medicine and UNC Lineberger Comprehensive Cancer Center. He discusses innovations and...
2.
Grover N, Hucks G, Riches M, Ivanova A, Moore D, Shea T, et al.
Lancet Haematol
. 2024 Mar;
11(5):e358-e367.
PMID: 38555923
Background: Chimeric antigen receptor (CAR) T cells targeting CD30 are safe and have promising activity when preceded by lymphodepleting chemotherapy. We aimed to determine the safety of anti-CD30 CAR T...
3.
Voorhees T, Zhao B, Oldan J, Hucks G, Khandani A, Dittus C, et al.
Blood Adv
. 2021 Oct;
6(4):1255-1263.
PMID: 34666347
Our group has recently demonstrated that chimeric antigen receptor T-cell therapy targeting the CD30 antigen (CD30.CAR-T) is highly effective in patients with relapsed and refractory (r/r) classical Hodgkin lymphoma (cHL)....
4.
Nakamura Z, Heiling H, Park E, Deal A, Quillen L, Chien S, et al.
Bone Marrow Transplant
. 2021 Oct;
56(12):3100-3103.
PMID: 34601501
No abstract available.
5.
Stadtmauer E, Sullivan K, El Idrissi M, Salaun B, Alonso Alonso A, Andreadis C, et al.
Hum Vaccin Immunother
. 2021 Aug;
17(11):4144-4154.
PMID: 34406911
Immunocompromised individuals, particularly autologous hematopoietic stem cell transplant (auHSCT) recipients, are at high risk for herpes zoster (HZ). We provide an in-depth description of humoral and cell-mediated immune (CMI) responses...
6.
Nakamura Z, Deal A, Park E, Quillen L, Chien S, Stanton K, et al.
J Psychosom Res
. 2021 May;
146:110503.
PMID: 33945982
Objective: To determine if high dose intravenous (IV) thiamine can prevent delirium during hospitalization following allogeneic HSCT. Secondarily, we evaluated the effects of high dose IV thiamine on thiamine levels...
7.
Copeland A, Tan X, Nash R, Holmes E, Markey J, Shea T, et al.
Psychooncology
. 2020 Sep;
30(1):118-122.
PMID: 32876970
No abstract available.
8.
Nakamura Z, Deal A, Rosenstein D, Quillen L, Chien S, Wood W, et al.
Support Care Cancer
. 2020 Aug;
29(4):2007-2014.
PMID: 32829465
Purpose: Cognitive impairment is common and consequential in patients with cancer who undergo allogeneic hematopoietic stem cell transplantation (HSCT). However, there is no standard of care for evaluating cognition in...
9.
Ramos C, Grover N, Beaven A, Lulla P, Wu M, Ivanova A, et al.
J Clin Oncol
. 2020 Jul;
38(32):3794-3804.
PMID: 32701411
Purpose: Chimeric antigen receptor (CAR) T-cell therapy of B-cell malignancies has proved to be effective. We show how the same approach of CAR T cells specific for CD30 (CD30.CAR-Ts) can...
10.
Nakamura Z, Deal A, Rosenstein D, Quillen L, Chien S, Wood W, et al.
Contemp Clin Trials
. 2020 Jul;
95:106076.
PMID: 32619524
Background: Delirium is a highly prevalent and preventable neuropsychiatric condition with major health consequences. Thiamine deficiency is a well-established cause of delirium in those with chronic, severe alcoholism, but there...